Tag: Health

news-27112024-055630

Jay Bhattacharya: Trump’s Choice to Lead NIH

President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being chosen for the position, as announced by his transition team...
news-02122024-152130

Investigating the Mildness of U.S. Bird Flu Cases: Scientists’ Mystery

U.S. Bird Flu Cases Mystify Scientists: An Unprecedented PhenomenonIn a remarkable turn of events, the United States has witnessed an outbreak of H5N1 avian influenza among cattle that has perplexed scientists and health authorities...
news-17112024-001110

New MPOX Strain Detected in California – First U.S. Case

California recently reported the first case of a new strain of mpox, a virus that is spreading from person to person. The infected individual had traveled from Eastern Africa, where the virus is currently...
news-18112024-121536

RFK Jr. as HHS Secretary: Scientists’ Opinions and Analysis

President-elect Donald Trump has chosen Robert F. Kennedy Jr. to lead the Department of Health and Human Services. This decision has sparked controversy, as RFK Jr. is known for being a vaccine skeptic. The...
news-15112024-102143

Nominate Vaccine Skeptic RFK Jr. to Run HHS: Trump’s Controversial Decision

President-elect Trump has selected Robert F. Kennedy Jr., an environmental lawyer and vaccine skeptic, as his choice to lead the Department of Health and Human Services. Trump made the announcement on Truth Social, expressing...
eli-lilly-to-test-obesity-medications-for-alcohol-and-drug-addiction-ceo-announces-study

Eli Lilly to Test Obesity Medications for Alcohol and Drug Addiction: CEO Announces Study

Eli Lilly Breaks New Ground in Addiction Treatment ResearchEli Lilly, the pharmaceutical giant behind the popular weight loss drug Zepbound, has made a groundbreaking announcement. The company is set to embark on a study...
news-26112024-115233

Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
news-08112024-220349

Inside the Therapist’s Room: A Look at the 2024 Election

I stand before my bathroom mirror, trying to calm my breathing. It's the morning after the election, and I just found out the results an hour ago. I've rushed through my morning routine, feeling...
news-22102024-032124

Navigating Ultra-Processed Foods: Dietary Experts’ Advice

Scientific experts working on the development of the 2025-2030 Dietary Guidelines for Americans recently discussed the challenges of including ultra-processed foods due to a lack of a clear definition and limited scientific research on...
news-28112024-120413

Understanding the Urgency of the BIOSECURE Act for Biosecurity Measures

The BIOSECURE Act, a piece of legislation targeting Chinese biotechnology companies, has been the center of attention in Washington early this year. However, the fate of this bill hangs in the balance as Congress...
news-17112024-061144

CRISPR Therapy Shows Superior Benefit for Cardiomyopathy Patients

Intellia Therapeutics CEO John Leonard has been facing a familiar situation for the past few years. The company has been sharing positive results from its gene editing trials, only to see its stock prices...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...